Greenlight Energy

GreenLight Biosciences is a biotechnology company dedicated to making RNA-based solutions affordable and accessible for human health and agriculture. The company utilizes a proprietary cell-free RNA manufacturing platform that overcomes the cost and scalability limitations of traditional fermentation-based production methods. In its human health division, GreenLight focuses on developing mRNA vaccines and therapeutics for infectious diseases, including COVID-19 and shingles. Simultaneously, its plant health division creates double-stranded RNA (dsRNA) products to protect crops from pests like the Colorado potato beetle, offering an environmentally friendly alternative to chemical pesticides. The company was taken private in 2023 to further accelerate the commercialization of its diverse RNA pipeline.